Stats bulletin 2015
Belgium
Bulgaria
Data and statistics
Data: statistical bulletin 2015 [ARCHIVE]
Please note: this is a data archive. For the most recent data and statistics, please see the the main Data and statistics section of our website.
The data presented here cover a broad range of areas including the most recent estimates of treatment and prevalence, drug-related infectious diseases, high risk drug use estimate, levels of drug related deaths, drug related crime in the form of drug seizures, types of offence, price, purity and use in prison, and country responses to the drug situation in Europe.
Date of last update: 04 June 2015.
The data is largely based on data submitted to the EMCDDA by the Reitox network of focal points and is the result of close cooperation between focal points and experts at the country level, and the EMCDDA at the European level.
Methods and definitions
Methods and definitions used can be found on the methods and definitions section.
About the data
The information provided here may be freely reused, provided it is reproduced accurately, not presented in a misleading way and that all sources are acknowledged.
To get started browsing the latest data on drugs in Europe, first select a starting point. Each option below provides you with a different way of exploring the data so select the one that best suits your needs.
Data tables by topic
Select this option to view datasets by topic and category, for all countries. All available data is shown.
Visualisations
Select this option to explore the data visually through maps and charts.
Search by country
Select this option you to view data for one or more countries. Good for comparing data between countries.
Technical notes
The following browsers are supported: Chrome 9 and later, Firefox 4 and later, Internet Explorer 9 and later, Safari 5 and later. Other browsers may also work but haven't been tested. Because of the quantity of data, the data is currently only available as an interactive product (i.e. you must have JavaScript enabled, which is the case by default on most browsers).
Our aim is to make this data available to as many users as possible so, if you have specific needs or encounter technical difficulties, please do not hesitate to contact us at online@emcdda.europa.eu.
Select some data
Select a general area of interest from the menu on the left. Explore each of these datasets by navigating through the tree. Larger datasets may take a few moments the first time you click on them. Much of the data can be viewed directly in your browser, though some data is only available as downloaded Excel files.
Visualisations
Prevalence
- Last year prevalence of cannabis use among young adults (15–34)
- Last year prevalence of cocaine use among young adults (15–34
- Last year prevalence of amphetamines use among young adults (15–34)
- Last year prevalence of ecstasy use among young adults (15–34)
- Last year prevalence among young adults (15–34): general population and club-goers (10 countries)
Treatment demand
- Cocaine users entering treatment (infographic)
- Cannabis users entering treatment (infographic)
- cannabis users entering treatment (infographic)
- Treatment entrants citing opioids as primary drug
- Trends in age structure of clients entering treatment by primary drug
- Heroin users entering treatment (infographic)
- Numbers receiving drug treatment in Europe in 2013, by setting
- Trends in percentage of clients entering specialised drug treatment services, by primary drug
- First-time treatment entrants reporting injecting as the main route of administration of their primary drug
Drug-related infectious diseases
- National estimates of last year prevalence of high-risk opioid use
- Newly diagnosed HIV cases related to injecting drug use
- HCV antibody prevalence among injecting drug users, 2012/2013
Drug-related deaths and mortality
- Number of drug-induced deaths by age group in 2006 and in 2013
- Drug-induced mortality rates among adults (15–64)
- Drug-induced deaths (infographic)
Seizures of drugs
- Proportion of reported number of seizures for the main illicit drugs, 2013
- Trends in number of cannabis seizures and quantity seized
- Number of heroin seizures and quantity seized
- Number of cocaine seizures and quantity seized
- Number of amphetamine seizures and quantity seized
- Number of methamphetamine seizures and quantity seized
- Numbers of MDMA seizures and tablets seized
Health and social responses
- Trends in number of clients in opioid substitution treatment
- Percentage of problem opioid users receiving substitution treatment (estimate)
- Number of syringes provided through specialised programmes per injecting drug user (estimate)
Proportion of reported number of seizures for the main illicit drugs, 2013
Trends in number of cannabis seizures and quantity seized
Resin, number of seizures
Resin, quantity seized (kilograms)
Herb, number of seizures
Herb, quantity seized (kilograms)
Number of heroin seizures and quantity seized
Number of seizures, trends
Quantity seized, trends
Number of seizures, 2013
Quantity seized, 2013
Number of cocaine seizures and quantity seized
Number of seizures, trends
Quantity seized, trends
Number of seizures, 2013 (or most recent year)
Quantity seized, 2013 (or most recent year)
Number of amphetamine seizures and quantity seized
Number of seizures, trends
Quantity seized, trends
Number of seizures, 2013 (or most recent year)
Quantity seized, 2013 (or most recent year)
Number of methamphetamine seizures and quantity seized
Number of seizures, trends
Quantity seized, trends
Number of seizures, 2013 (or most recent year)
Quantity seized, 2013 (or most recent year)
Numbers of MDMA seizures and tablets seized
Number of seizures, trends
Quantity seized, trends
Number of seizures, 2013 (or most recent year)
Quantity seized, 2013 (or most recent year)
Last year prevalence of cannabis use among young adults (15–34)
Most recent data
Countries with statistically significant trends: Germany, Spain and the United Kingdom
Countries with statistically significant trends: Bulgaria, Denmark, Finland, France and Sweden
Infographic: cannabis users entering treatment
Last year prevalence of cocaine use among young adults (15–34)
Selected trends
Most recent data
Infographic: cocaine users entering treatment
Last year prevalence of amphetamines use among young adults (15–34)
Selected trends
Most recent data
Infographic: amphetamines users entering treatment
Last year prevalence of ecstasy use among young adults (15–34)
Selected trends
Most recent data
Last year prevalence among young adults (15–34): general population and club-goers (10 countries)
Sources: Global Drug Survey 2014 and the most recent general population surveys for the following countries: Belgium, Germany, Ireland, Spain, France, Hungary, Netherlands, Austria, Portugal, United Kingdom. Amphetamines: minus Belgium and Netherlands. Ecstasy: minus Netherlands.
National estimates of last year prevalence of high-risk opioid use
Trends
Most recent data
Treatment entrants citing opioids as primary drug
By type of opioid
Percentage reporting opioids other than heroin
Trends in age structure of clients entering treatment by primary drug
2006
2013
First-time treatment entrants reporting injecting as the main route of administration of their primary drug
First-time treatment entrants reporting injecting as the main route of administration of their primary drug
Infographic: heroin users entering treatment
Newly diagnosed HIV cases related to injecting drug use
Trends in number of cases
Most recent data (cases per million population)
Data for 2013 (source: ECDC).
HCV antibody prevalence among injecting drug users, 2012/2013
Number of drug-induced deaths by age group in 2006 and in 2013
Drug-induced mortality rates among adults (15–64)
Selected trends
Most recent data (cases per million population)
NB: Trends in the ten countries reporting the highest values in 2013.
Infographic: drug-induced deaths
Numbers receiving drug treatment in Europe in 2013, by setting
Trends in percentage of clients entering specialised drug treatment services, by primary drug
Trends in number of clients in opioid substitution treatment
Percentage of problem opioid users receiving substitution treatment (estimate)
Number of syringes provided through specialised programmes per injecting drug user (estimate)
Select up to 15 countries.
Select some data.
Use the menu on the far left to select from one to six countries. Select areas of interest from the second menu (as many as you like). Larger datasets may take a few moments the first time you click on them. Much of the data can be viewed directly in your browser, though some data is only available as downloaded Excel files.
About the EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>
Contact
The EMCDDA is located at:
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
